KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Total Liabilities (2016 - 2025)

Novartis Ag's Total Liabilities history spans 13 years, with the latest figure at $64.4 billion for Q4 2025.

  • On a quarterly basis, Total Liabilities rose 10.81% to $64.4 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $64.4 billion, a 10.81% increase, with the full-year FY2025 number at $64.4 billion, up 10.81% from a year prior.
  • Total Liabilities hit $64.4 billion in Q4 2025 for Novartis Ag, up from $62.3 billion in the prior quarter.
  • Over the last five years, Total Liabilities for NVS hit a ceiling of $64.4 billion in Q4 2025 and a floor of -$64.0 billion in Q2 2021.
  • Historically, Total Liabilities has averaged $35.3 billion across 5 years, with a median of $58.1 billion in 2022.
  • Biggest five-year swings in Total Liabilities: decreased 10.04% in 2021 and later soared 201.75% in 2023.
  • Tracing NVS's Total Liabilities over 5 years: stood at $64.0 billion in 2021, then fell by 9.29% to $58.0 billion in 2022, then dropped by 8.33% to $53.2 billion in 2023, then rose by 9.26% to $58.1 billion in 2024, then grew by 10.81% to $64.4 billion in 2025.
  • Business Quant data shows Total Liabilities for NVS at $64.4 billion in Q4 2025, $62.3 billion in Q2 2025, and $58.1 billion in Q4 2024.